ArticleAsian Pacific journal of cancer prevention : APJCP2023
Evaluation of Patient-Specific Quality Assurance in Single Isocenter Multitarget Stereotactic Radiosurgery of Brain Metastases Using Octavius 4D for Flattening Filter Free Beams.
Article in Asian Pacific journal of cancer prevention : APJCP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Rapid commissioning of Brainlab Elements for SRS: end-to-end evaluation of Monte Carlo and pencil beam algorithm across homogeneous and heterogeneous phantom environments.Frontiers in oncology · 2026Article
- Impact of enhanced leaf model on dose calculation accuracy in single-isocenter multitarget stereotactic radiosurgery treatments.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the patient-specific quality assurance (PSQA) in Single Isocenter Multitarget (SIMT) Stereotactic Radiosurgery (SRS) of brain metastases using Octavius 4D for flattening filter free (FFF) X-ray beams. MATERIALS AND
methodsOctavius 4D with 1000 SRS detector array was used for doing PSQA in fifteen patients planned using volumetric modulated arc therapy (VMAT) based stereotactic radiosurgery (SRS) of SIMT technique for treating multiple brain metastases. Measurements were made both in standard setup as well as in special setup through which the region of measurement is increased. The obtained results are compared with TPS reference doses at different dose grid sizes and minimum dose cutoff thresholds for both 6X-FFF and 10X-FFF energies.
resultsThe percentages of measurable targets were 83.34% and 93.54% in standard and special set respectively. In standard set, the average gamma passing rate was 97.63±1.26% and 97.78±1.09% for 6X-FFF and 10X-FFF respectively. The mean gamma passing rates was 97.97±0.99% and 97.85±1.13% for 6X-FFF and 10X-FFF in special set respectively. PSQA passing rate decreases with increasing TPS grid size in both the energies. The mean gamma passing rate for 6X-FFF was 97.97±0.99% and 96.94±1.11% at 10% and 25% cutoff dose respectively. The mean gamma passing rate for 10X-FFF at 10% and 25% dose cutoff was 97.85±1.13% and 97.12±1.29% respectively. Low-dose masking effect was more in 6X-FFF than observed with 10X-FFF energy.
conclusionThe performance of Octavius 1000 SRS for PSQA of VMAT based SRS were evaluated and found satisfactory at 6X-FFF and 10X-FFF energies in SIMT of brain metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.